Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Plowden v. Similasan Corp.
Case Number:
1:23-cv-02511
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
November 07, 2024
Eye Drop Maker To Pay $3.6M To Settle Class Claims
A maker of homeopathic eye drops has agreed to pay nearly $3.6 million to settle claims its products are being sold as drugs without U.S. Food and Drug Administration approval and don't meet manufacturing safety standards, according to a preliminary settlement agreement filed Wednesday.
-
November 21, 2023
Eye Drop Users Can't Turn FDA Warning Into Injury, Co. Says
The maker of homeopathic eye drops is urging a Colorado federal court to throw out a lawsuit from an individual who the company said got "exactly what he paid for" when buying a red-eye relief product.
-
September 27, 2023
Class Claims Homeopathic Eye Products Being Sold Illegally
A proposed class of buyers is suing an eye drop maker in Colorado federal court, alleging that its "homeopathic" products are being sold as drugs without approval from the U.S. Food and Drug Administration and their manufacturer does not follow proper safety standards.